Why is Transgene Biotek falling/rising?

As of 19-Sep, Transgene Biotek Ltd's stock price is currently at 3.81, reflecting a decline of 0.14 or 3.54%. The stock has been underperforming, having fallen consecutively for the last two days, resulting in a total drop of 13.01% during this period. Additionally, it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. The stock has also experienced significant underperformance over the past month, with a decline of 12.41%, and a year-to-date drop of 44.22%. Although there has been a notable increase in investor participation, with delivery volume rising by 149.15% against the 5-day average, the absence of any positive factors in the dashboard suggests that the stock's recent movement is primarily negative.
In the broader market context, Transgene Biotek's short-term performance contrasts sharply with the benchmark, as the Sensex has gained 0.88% over the past week while Transgene Biotek has remained flat. Over the past month, the benchmark has increased by 1.20%, further highlighting the stock's struggles. Year-to-date, while the Sensex has risen by 5.74%, Transgene Biotek has seen a significant decline, underscoring its underperformance relative to the broader market. This disparity in performance may contribute to investor sentiment and the stock's downward trajectory.